Z-VDVAD-FMK 21843 two compounds with dual action

two compounds with dual action (TXRA and TXSI)

is approximately 100-fold more potent as an antagonist of the ER than tamoxifen

Pretreatment of 8-day-old rats with 5 mg/kg CGP 20712 A do not change the plasma ACTH response to insulin injection

6)20-10-8-19(9-11-20)12-16(2)13-22-14-17(3)23-18(4)15-22

twice daily for 16 d) increases CD8+ T cells infiltration and reverses immunosuppression in mice

Z-VDVAD-FMK 21843 two compounds with dual actionJurkat T lymphocytes treated with an irreversible caspase 2 inhibitor, benzyloxycarbonyl Val Asp(OMe) Val Ala Asp(OMe) fluoromethyl ketone (Z VDVAD FMK), or stably transfected with pro caspase 2 antisense (Casp 2 AS) are refractory to cytochrome c release stimulated by etoposide1. When etoposide induced activation of pro caspase 2 is subverted by Z VDVAD FMK or stable transfection of pro caspase 2 antisense, cytochrome c release and other